• Explore /
  • Poster
  • / Impact of immune checkpoint and BRAF inhibitors on the incidence of second primary malignancies (SPM) in melanoma.

Impact of immune checkpoint and BRAF inhibitors on the incidence of second primary malignancies (SPM) in melanoma.

Abstract Video & Slides Poster

Authors

null

Nibash Budhathoki

NYU Winthrop Hospital, Mineola, NY

Nibash Budhathoki , Sunita Timilsina , Prashanti Atluri , Jeffrey S. Weber , Marc Justin Braunstein

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Late and Long-Term Adverse Effects

Citation

J Clin Oncol 38: 2020 (suppl; abstr 12061)

DOI

10.1200/JCO.2020.38.15_suppl.12061

Abstract #

12061

Poster Bd #

349

Abstract Disclosures

Similar Posters

First Author: F. Stephen Hodi

First Author: Tulasi Gummadi

First Author: Ahmad A. Tarhini

First Author: Julie Williamson